Yong Man Kim
Fortune : 1 703 $ au 31/05/2026
Fortune : 1 703 $ au 31/05/2026
Yong Man Kim is currently Chief Scientific Officer & Director at NKMAX Co., Ltd. since 2021 and Chief Scientific Officer at NKGen Biotech, Inc. since 2023.
Former positions include Director, Chief Scientific & Innovation Officer at NKGen Operating Biotech, Inc. from 2021 to 2023 and Research Professor at Wonkwang University.
Education includes a doctorate from Chungnam National University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,02 % | 07/10/2025 | 28 384 ( 0,02 % ) | 1 703 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
NKMAX Co., Ltd.
NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies finished pharmaceutical products | Directeur Technique/Scientifique/R&D | 01/09/2017 |
| Sociétés | Poste | Fin |
|---|---|---|
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that manufactures natural killer cell therapies to treat cancer | Directeur Technique/Scientifique/R&D | 01/09/2023 |
Wonkwang University
Wonkwang University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Wonkwang University
Wonkwang University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chungnam National University
Chungnam National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NKMAX Co., Ltd.
NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies finished pharmaceutical products | Health Technology |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that manufactures natural killer cell therapies to treat cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national